Compare studies and check their requirements with the research team.
This study is completed in the United States. It is testing Safety and Efficacy of ASP4345 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety and Efficacy of Oral LPCN 1154A for Depression.
In United StatesThis study is completed in the United States. It is testing brexanolone for depression.
In United StatesThis study is completed in the United States. It is testing safety, Efficacy, and Pharmacokinetics of Miricorilant for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability and Efficacy of RG2417 for depression.
In United StatesThis study is completed in the United States. It is testing Multiple Doses of ASP8062 With a Single Dose of Morphine for Addiction.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 for schizophrenia.
In United StatesThis study is completed in the United States, in the United Kingdom, and in Ireland. It is testing use of Methylone for PTSD.
In United States
This study is completed in the United States. It focuses on Suicide prevention.
In United StatesThis study is completed in the United States. It focuses on Addiction.
In United StatesThis study is completed in the United States, in Brazil, and in Mexico. It focuses on schizophrenia.
In United StatesThis study is completed in the United States. It focuses on depression.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.